JC-Virus (JCV) Antibody Program
Sort
Pubmeds
(0)
JC-Virus (JCV) Antibody Program
Description
The primary objective is to define the prevalence of serum anti-JCV antibody in relapsing multiple sclerosis (MS) participants receiving Tysabri® (natalizumab) or being considered for such treatment. Secondary objectives are to analytically validate the anti-JCV antibody assay in a plasma matrix and to determine changes in anti-JCV antibody status over time.
1
2
2
1